These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration. Schmidt-Erfurth U; Vogl WD; Jampol LM; Bogunović H Ophthalmology; 2020 Sep; 127(9):1211-1219. PubMed ID: 32327254 [TBL] [Abstract][Full Text] [Related]
5. Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials. Core JQ; Pistilli M; Daniel E; Grunwald JE; Toth CA; Jaffe GJ; Hua P; Martin DF; Ying GS; Maguire MG; Ophthalmol Retina; 2021 Oct; 5(10):962-974. PubMed ID: 34126249 [TBL] [Abstract][Full Text] [Related]
6. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration. Lee JY; Chung H; Kim HC Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799 [TBL] [Abstract][Full Text] [Related]
8. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization. Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073 [TBL] [Abstract][Full Text] [Related]
9. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Lee H; Ji B; Chung H; Kim HC Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214 [TBL] [Abstract][Full Text] [Related]
10. EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies. Dugel PU; Jhaveri CD; Chakravarthy U; Wykoff CC; Singh RP; Hamilton R; Weissgerber G; Mulyukov Z; Holz FG Retina; 2022 Mar; 42(3):511-518. PubMed ID: 34923515 [TBL] [Abstract][Full Text] [Related]
11. Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic. Borrelli E; Grosso D; Vella G; Sacconi R; Battista M; Querques L; Zucchiatti I; Prascina F; Bandello F; Querques G Graefes Arch Clin Exp Ophthalmol; 2020 Dec; 258(12):2621-2628. PubMed ID: 33009973 [TBL] [Abstract][Full Text] [Related]
12. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Shin JY; Kwon KY; Byeon SH Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639 [TBL] [Abstract][Full Text] [Related]
13. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography. Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338 [TBL] [Abstract][Full Text] [Related]
14. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ; Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095 [TBL] [Abstract][Full Text] [Related]
15. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY. Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691 [TBL] [Abstract][Full Text] [Related]
16. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Golbaz I; Ahlers C; Stock G; Schütze C; Schriefl S; Schlanitz F; Simader C; Prünte C; Schmidt-Erfurth UM Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1599-605. PubMed ID: 21051733 [TBL] [Abstract][Full Text] [Related]
18. Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration. Keenan TDL; Chakravarthy U; Loewenstein A; Chew EY; Schmidt-Erfurth U Am J Ophthalmol; 2021 Apr; 224():267-281. PubMed ID: 33359681 [TBL] [Abstract][Full Text] [Related]
19. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration. Inan S; Polat O; Karadas M; Inan UU Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625 [No Abstract] [Full Text] [Related]
20. Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD. von der Burchard C; Treumer F; Ehlken C; Koinzer S; Purtskhvanidze K; Tode J; Roider J Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1623-1629. PubMed ID: 29915918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]